Harrow Health Inc. 11.875...

26.70
-0.15 (-0.56%)
At close: Mar 28, 2025, 3:23 PM
26.70
0.00%
After-hours: Mar 28, 2025, 04:00 PM EDT

Company Description

Harrow, Inc. engages in the development, production, and sale of innovative medications.

It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development.

The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business.

The company was founded by Mark L.

Baum and Robert J.

Kammer in January 2006 and is headquartered in Nashville, TN.

Harrow Health Inc. 11.875% Senior Notes due 2027
Harrow Health Inc. 11.875% Senior Notes due 2027 logo
Country United States
IPO Date Dec 29, 2022
Industry Medical - Pharmaceuticals
Sector Healthcare
Employees 217
CEO Mark L. Baum

Contact Details

Address:
No Address available
Nashville,
United States
Website http://www.harrowinc.com

Stock Details

Ticker Symbol n/a
Exchange NASDAQ
Fiscal Year n/a
Reporting Currency USD
CIK Code n/a
CUSIP Number n/a
ISIN Number US4158583074
Employer ID -
SIC Code n/a

Key Executives

No executives data available.

Latest SEC Filings

No SEC filings available.